Rep. Kevin Hern (R-Okla.) reported the sale of Procter & Gamble Company (PG) stock in a new Periodic Transaction Report filed with the U.S. House of Representatives, as required under the STOCK Act. The transaction was executed through a jointly-held account shared with his spouse, and the filing lists the holding as running through the Hern Family Foundation.
According to the disclosure, the sale took place on August 5, 2026, with the value of the transaction falling between $1,001 and $15,000. The filing does not specify a per-share price or a precise dollar figure, which is standard practice for these reports; members of Congress are only required to disclose a value range rather than exact amounts. Our internal tracking system classifies this filing as a straightforward congress sale, meaning the member’s household reduced its position in PG rather than adding to it.
An Insider Sold PG Stock the Next Day
What makes this filing notable is its timing relative to activity elsewhere at Procter & Gamble. Company insider Janzaruk Matthew W. also sold PG shares on August 6, 2026 — just one day after Hern’s reported transaction date, and both sales fall within the same 30-day window. The insider transaction was recorded at $0 in disclosed value, a detail that sometimes reflects non-cash transfers, option exercises, or other structured transactions rather than a typical open-market sale.
Neither transaction, on its own or together, is evidence of coordination or improper conduct. Members of Congress and corporate insiders are both subject to separate, well-established disclosure regimes — the STOCK Act for lawmakers and SEC Form 4 filings for company insiders — and overlapping activity in the same stock over a short window is not unusual, particularly for a widely held, large-cap name like Procter & Gamble. Still, when a lawmaker’s sale and a company insider’s sale land within days of each other, it is the kind of pattern that readers tracking PG activity may want to note.
This is not the first PG-related filing our team has covered recently. Just last month, a separate report detailed Rep. Lloyd Doggett’s purchase of PG stock via dividend reinvestment, illustrating how differently members of Congress are positioning themselves around the same equity in the same general timeframe.
As always, this reporting is based solely on the publicly filed disclosure and is intended to inform readers about congressional trading activity, not to suggest any investment action or imply wrongdoing by either the member of Congress or the company insider involved.